Theralase Technologies Inc. designs, develops, manufactures and markets patented, superpulsed laser technology utilized in biostimulation and biodestruction applications. The technology is safe and effective in the treatment of chronic pain, neural muscular-skeletal conditions and wound care. When combined with its patented, light-sensitive Photo Dynamic Compounds, Theralase laser technology is able to specifically target and destroy cancers, bacteria and viruses. Theralase lasers are FDA, Health Canada and CSA/UL approved, and have international ISO 13485 certification.
Theralase's strategy includes two parts: production, marketing and distribution of the Theralase super-pulsed laser for sale to health-care practitioners (focusing on the treatment of chronic pain, sports injuries and wounds); and commercialization of (i) patented cancer treatment through progressive research, clinical trials and advancement of new technology in the direct destruction of cancers and (ii) destruction of bacteria and viruses through research utilizing patented, light-sensitive Photo Dynamic Compounds
"I was pretty sceptical," says Mr. Dumoulin-White. "It was something my father came across while traveling in Europe. He also gave me an anecdotal study translated from Flemish that showed using 905 nanometre light, which is invisible laser light, increased cellular mitosis of fibroblasts by 100%."
Cold Lasers For an Aging Population:Geriatric Conditions
Laser Therapy